Do clinical, histological or immunohistochemical primary tumour characteristics translate into different 18F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?
Crossref DOI link: https://doi.org/10.1007/s00259-015-3110-x
Published Online: 2015-07-04
Published Print: 2015-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Groheux, David
Majdoub, Mohamed
Tixier, Florent
Le Rest, Catherine Cheze
Martineau, Antoine
Merlet, Pascal
EspiƩ, Marc
de Roquancourt, Anne
HindiƩ, Elif
Hatt, Mathieu
Visvikis, Dimitris
Text and Data Mining valid from 2015-07-04